Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

News|Videos|March 5, 2025

Patient Selection and Billing Considerations for Swift Wart Treatment

Author(s)Sponsored by Swift

Dustin Portela, DO, discusses patient selection and affordability considerations for Swift microwave therapy. He explores how the treatment process works and strategies to ensure patient comfort during sessions.

Episodes in this series

EP. 1 Introduction of Swift Microwave Therapy for Wart Treatment

EP. 1 Introduction of Swift Microwave Therapy for Wart Treatment

EP. 2 Traditional vs Microwave Wart Therapies: Insights from Swift’s Efficacy Data

EP. 2 Traditional vs Microwave Wart Therapies: Insights from Swift’s Efficacy Data

EP. 3 Microwave Treatment: Advantages Over Traditional Approaches

EP. 3 Microwave Treatment: Advantages Over Traditional Approaches

EP. 4 Patient Selection and Billing Considerations for Swift Wart Treatment

EP. 4 Patient Selection and Billing Considerations for Swift Wart Treatment

EP. 5 Practicing With Swift: Impacts and Opportunities Created

EP. 5 Practicing With Swift: Impacts and Opportunities Created

EP. 6 Operational Benefits With Swift As a Delegable Procedure

EP. 6 Operational Benefits With Swift As a Delegable Procedure

EP. 7 Key Takeaways for Adding Swift Wart Treatment to Your Practice

EP. 7 Key Takeaways for Adding Swift Wart Treatment to Your Practice

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis

New Consensus Defines Remission, Disease Activity in Atopic Dermatitis

Beyond Retinol: Evaluating the Stability, Safety, and Gene-Expression Profile of Bakuchiol Ferulate

Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites

AI-Assisted Imaging Tracks Success of Low-Fluence QSRL Laser for Melasma